Participation and influence of individuals and committees that decide on drug availability in HMOs

American Journal of Health-System Pharmacy

Volumn 55, Issue 1, 1998, Pages 56-61

  Barner, Jamie C ^a   Thomas III, Joseph ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Administration; Administrators; Committees; Data collection; Decision making; Drug information; Drugs; Formularies; Health maintenance organizations; Nurses; Pharmacists, institutional; Pharmacy and therapeutics committees; Pharmacy, institutional

Indexed keywords

ARTICLE; DATA ANALYSIS; DRUG BIOAVAILABILITY; DRUG INFORMATION; HEALTH MAINTENANCE ORGANIZATION; HEALTH SURVEY; MEDICAL DECISION MAKING; PRIORITY JOURNAL; QUESTIONNAIRE;

EID: 0031963537     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/55.1.56     Document Type: Article

References (9)

1. Matthyssens P, Van den Bulte C. Getting closer and nicer. Partnerships in the supply chain. Long Range Plann. 1994; 27 (1):72-83.
2. Webster FE, Wind Y. Organizational buying behavior. New York: Prentice-Hall; 1972.
3. Barclay DW. Organizational buying outcomes and their effects on subsequent decisions, EM J Mark. 1992; 26:48-64.
4. Robinson PJ, Farris CW, Wind Y. Industrial buying and creative marketing. Boston: Allyn and Bacon; 1967.
5. Ramaswamy K. Drug therapeutic index, attribute determinance, and participation of various personnel in drug product choice decisions in hospitals. West Lafayette, IN: Purdue University; 1993. Thesis.
6. GHAA 1993 national directory of HMOs. Washington, DC: Group Health Association of America; 1993.
7. SAS/FSP software: usage and reference, version 6, 1st ed. Cary, NC: SAS Institute; 1990.
8. SAS procedures guide, Version 6, 3rd ed. Cary, NC: SAS Institute; 1990.
9. Managed care digest: HMO edition 1994. Kansas City, MO: Marion Merrell Dow; 1994.